BSEM BioStem Technologies Inc.

OTC
$3.21

BioStem Technologies Inc. (BSEM) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.46 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +39.6% since its last earnings release on August 12, 2026.

BioStem Technologies Missed Consensus Estimates
Wednesday, August 12, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.46)
Rev est $8M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.12

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BioStem Technologies Inc.

ioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts for regenerative therapies.

Sector

Healthcare

Industry

Biotechnology